TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43,933
|
46,601
|
38,623 |
Financial expenses |
1
|
7
|
15 |
Earnings before taxes |
4,730
|
4,787
|
4,875 |
EBITDA |
4,734
|
4,829
|
4,937 |
Total assets |
16,731
|
19,279
|
17,593 |
Current assets |
15,052
|
17,569
|
15,687 |
Current liabilities |
4,854
|
8,046
|
6,411 |
Equity capital |
10,055
|
9,557
|
9,523 |
- share capital |
336
|
334
|
364 |
Employees (average) |
6
|
5
![]() |
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.1%
|
49.6%
|
54.1% |
Turnover per employee |
7,322
|
9,320
|
7,725 |
Profit as a percentage of turnover |
10.8%
|
10.3%
|
12.6% |
Return on assets (ROA) |
28.3%
|
24.9%
|
27.8% |
Current ratio |
310.1%
|
218.4%
|
244.7% |
Return on equity (ROE) |
47.0%
|
50.1%
|
51.2% |
Change turnover |
-2,908
|
11,107
|
-3,697 |
Change turnover % |
-6%
|
31%
|
-9% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
20%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.